As a fifth-grade teacher with three children and two grandchildren, Tim is always on the move, whether he’s teaching, surfing, cycling, or enjoying the outdoors with his family. Tim never thought he’d be battling prostate cancer at 52 years old. After the initial shock of diagnosis, he decided he couldn’t let prostate cancer slow him down. When his cancer spread after two years of treatment, his doctor recommended PROVENGE, which he received in early in 2012. Tim’s fifth-grade students still keep his life busy, but his family helps him live it to the fullest.

 
 

Diagnosed with prostate cancer more than 15 years ago at the age of 62, Don was told he wouldn't likely live more than 5 or 10 years. After enduring multiple treatments including surgery, radiation, and hormone treatments, Don was put on PROVENGE in 2011 and never looked back. Don used to say he always wanted to be 80 years old. Now, with that age just around the corner, he's excited about the possibility of reaching 90! With his renewed zest for life, Don and his wife Kris are planning to travel more, but while they are home on their 30 acre farm, they enjoy the comfort of their animals and managing their booming fine art and document restoration business.

 
 

Bob is an active 84-year-old who spent over three decades as an engineer at the world’s leading aerospace company working with civilian as well as air force and navy customers. He is now retired and enjoys spending his free time with his wife, two sons and four granddaughters. He has many hobbies, including building model airplanes in his home workshop.

Bob was diagnosed with prostate cancer in 1996. Radiation put the disease into remission for several years, but the cancer returned and spread to his bones. Bob’s physician recommended he participate in a Phase 3 clinical trial for PROVENGE.

 
 

When it comes to battling prostate cancer, Ray is a self-acknowledged fighter, but he always has a smile to offer and a lighthearted story to tell. He has undertaken many treatments, including hormone therapy, surgery, chemotherapy and radiation, since he was first diagnosed with prostate cancer. Several years ago, his physician suggested that he participate in a Phase 3 clinical trial for PROVENGE.

 
 

“I was born and raised in Lexington, Virginia, raised in the mountains, and at 17, went in the Army. When I got back, I worked in the shipyard for most of my life.” Ken has 6 children and 17 grandchildren that help him stay young.

However, in the last 10 years, Ken has encountered some serious health problems. From back surgery, to a heart bypass, to metastatic prostate cancer – Ken is used to fighting for his health. After undergoing several treatments for prostate cancer, Ken’s doctor recommended he participate in a Phase 3 clinical trial for PROVENGE.

 
 

Rollin hasn’t let his 19-year battle with prostate cancer hold him back from doing what he loves most: packing up his RV and traveling all over the country to visit friends and family. When Rollin’s physician told him about a clinical trial of PROVENGE, Rollin was eager to explore this innovative treatment option. Rollin’s physicians and faith keep him optimistic about the future, and he enjoys living life to the fullest. Aside from his wife and three sons, Rollin spends quality time with the “Sun Ray Eight” – his close-knit group of Floridian friends.

 
 

When Bob first learned he had prostate cancer eleven years ago, his initial concerns were about his family. That’s why Bob pursued the opportunity to be treated with PROVENGE as soon as it was approved by the FDA. Bob was intrigued by the unique approach and the potential to use the power of his own cells to combat his cancer. He lives with hope that one day, immunotherapies like PROVENGE will be able to help his son and nephews if they need to fight similar battles. At age 68, Bob enjoys attending gourmet dinner groups with his wife, spending time with his children and grandchildren on their annual family vacations, and pursuing his hobby of building – and racing – scale-sized trolley train cars.

 
 
Provenge.com

An innovative option in the fight against advanced prostate cancer, PROVENGE® (sipuleucel-T) is the only FDA-approved treatment that uses the body's own immune system to fight the disease.

LEARN
MORE >>

 
OUR PRODUCT PLATFORM

PROVENGE is different from other kinds of prostate cancer medicine. To see how PROVENGE is manufactured and designed to work, watch a video that explains the PROVENGE process.

PROVENGE
JOURNEY
VIDEO >>

INVESTOR INFORMATION

Visit Dendreon Investor Relations to find investor and media information, use our investor tools, and subscribe to keep up to date on the latest Dendreon news.

LEARN
MORE >>

INDICATION: PROVENGE® (sipuleucel-T) is approved by the FDA as an autologous cellular immunotherapy for the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer.
Important Safety Information | Full Prescribing Information